BlackRock’s GT Biopharma GTBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.9K | Hold |
9,737
| – | – | ﹤0.01% | 4985 |
|
|
2025
Q1 | $20.9K | Hold |
9,737
| – | – | ﹤0.01% | 5036 |
|
|
2024
Q4 | $29.7K | Hold |
9,737
| – | – | ﹤0.01% | 4990 |
|
|
2024
Q3 | $22.5K | Sell |
9,737
-31
| -0.3% | -$72 | ﹤0.01% | 4873 |
|
|
2024
Q2 | $27.6K | Sell |
9,768
-364
| -4% | -$1.03K | ﹤0.01% | 4908 |
|
|
2024
Q1 | $44.9K | Sell |
10,132
-3
| -0% | -$13 | ﹤0.01% | 4833 |
|
|
2023
Q4 | $77.5K | Hold |
10,135
| – | – | ﹤0.01% | 4800 |
|
|
2023
Q3 | $73.3K | Sell |
10,135
-25
| -0.2% | -$181 | ﹤0.01% | 4854 |
|
|
2023
Q2 | $95.1K | Sell |
10,160
-2,342
| -19% | -$21.9K | ﹤0.01% | 4845 |
|
|
2023
Q1 | $206K | Buy |
12,502
+76
| +0.6% | +$1.25K | ﹤0.01% | 4676 |
|
|
2022
Q4 | $330K | Buy |
12,426
+33
| +0.3% | +$877 | ﹤0.01% | 4633 |
|
|
2022
Q3 | $654K | Sell |
12,393
-159
| -1% | -$8.39K | ﹤0.01% | 4549 |
|
|
2022
Q2 | $1.13M | Sell |
12,552
-25,822
| -67% | -$2.31M | ﹤0.01% | 4402 |
|
|
2022
Q1 | $3.32M | Sell |
38,374
-494
| -1% | -$42.7K | ﹤0.01% | 4090 |
|
|
2021
Q4 | $3.56M | Buy |
38,868
+360
| +0.9% | +$32.9K | ﹤0.01% | 4077 |
|
|
2021
Q3 | $7.79M | Sell |
38,508
-8,605
| -18% | -$1.74M | ﹤0.01% | 3734 |
|
|
2021
Q2 | $21.9M | Buy |
+47,113
| New | +$21.9M | ﹤0.01% | 3188 |
|